Big Pharma is for Profits

by , under Big Pharma, Contemporary Cancer Topics, The Cancer Industry

It is not a bad thing to be run a business for profit.  Unfortunately, there can be a conflict between financial interests and what is best for the patient.  Given the present corporate paradigm where profits are the first, highest priority, this can have disastrous ramifications for medical policy.  A goal of more profit may motivate Big Pharma companies to sell expensive drugs to patients even though they may not be radically different from older, cheaper drugs.


Doctors are often willing victims of Big Pharma.  Their medical educations are heavily influenced by pharmaceutical companies.  It is to the point now where there are incredibly large numbers of prescriptions written by physicians.  It is as if there is believed to be no other way to treat patients.  Big Pharma spends many billions of dollars per year to market their drugs and to get physicians to write prescriptions for them. Some doctors and other medical professionals are working to break this influence.  But it will be very tough to do because pharmaceutical companies spend so much money on medical professionals, advertising to patients and buying influence with Congress and other government regulators.

Health care is a business.  I remember a time when medical professionals cared about patients and what was best for the patient was the first, highest priority.  You didn’t hear about sick and/or injured people being turned away from an emergency room because they didn’t have the right insurance, or any insurance.  You didn’t hear about people being sent home sick, or vast numbers of people being driven into bankruptcy from medical bills.  There were probably some things that were improved by turning health care into a ‘for-profit’ business, but there were also a lot of things that got worse.

Big Pharma and health care is now ran by business executives that see everything in financial terms.  The safety or efficacy of a particular drug is not as important a priority as the profits that can be generated.  Profit is a good thing.  But when profits are more important than patient well-being, there is a problem with this.  It reduces the value of people, and leads to people being viewed as a way to financial gain.  This may be why profitable paradigms are supported and defended, and why unprofitable, but safer, more effective treatment modalities are rejected and suppressed.

Think about the obvious failures of chemotherapy, radiation and surgery in this context, and it may make a lot more sense to you why these highly profitable treatments are vehemently protected and worshiped, while any and every other alternative to this is summarily dismissed as quackery.  Do you really think that it is a coincidence?

Leave a Reply